Cutting edge: The RIG-I ligand 3pRNA potently improves CTL cross-priming and facilitates antiviral vaccination

Journal of Immunology

Volumn 196, Issue 6, 2016, Pages 2439-2443

  Hochheiser, Katharina ^a,c   Klein, Marika ^a   Gottschalk, Catherine ^a   Hoss, Florian ^a   Scheu, Stefanie ^b   Coch, Christoph ^a   Hartmann, Gunther ^a   Kurts, Christian ^a  

^a UNIVERSITY OF BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; IMMUNOLOGICAL ADJUVANT; INTERFERON; MEMBRANE PROTEIN; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TRIPHOSPHATE RNA; UNCLASSIFIED DRUG; DDX58 PROTEIN, MOUSE; DEAD BOX PROTEIN; IPS-1 PROTEIN, MOUSE; LIGAND; RNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRUS VACCINE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENSITY GRADIENT CENTRIFUGATION; FLOW CYTOMETRY; MACROPHAGE; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN CELL; VACCINATION; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CROSS-PRIMING; DEAD-BOX RNA HELICASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LIGANDS; MICE; RNA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL VACCINES;

EID: 84962585468     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501958     Document Type: Article

References (27)

1. Hemmi, H., and S. Akira. 2005. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86:120-135.
2. Hornung, V., J. Ellegast, S. Kim, K. Brzózka, A. Jung, H. Kato, H. Poeck, S. Akira, K. K. Conzelmann, M. Schlee, et al. 2006. 59-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
3. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell typespecific involvement of RIG-I in antiviral response. Immunity 23:19-28.
4. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
5. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NFkappaB and IRF 3. Cell 122:669-682.
6. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
7. + T cells stimulated by virusinduced type I interferon. Nat. Immunol. 4:1009-1015.
8. +) but not CD8 (-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696.
9. + dendritic cells in cytotoxic T cell immunity. Science 322:1097-1100.
10. Tussiwand, R., W. L. Lee, T. L. Murphy, M. Mashayekhi, W. Kc, J. C. Albring, A. T. Satpathy, J. A. Rotondo, B. T. Edelson, N. M. Kretzer, et al. 2012. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490:502-507.
11. Gottschalk, C., V. Damuzzo, J. Gotot, R. A. Kroczek, H. Yagita, K. M. Murphy, P. A. Knolle, I. Ludwig-Portugall, and C. Kurts. 2013. Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens. J. Am. Soc. Nephrol. 24:543-549.
12. Engel, D. R., T. A. Krause, S. L. Snelgrove, S. Thiebes, M. J. Hickey, P. Boor, A. R. Kitching, and C. Kurts. 2015. CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages. J. Immunol. 194:1628-1638.
13. + T (reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens. Eur. J. Immunol. 39:225-233.
14. Hardy, S., M. Kitamura, T. Harris-Stansil, Y. Dai, and M. L. Phipps. 1997. Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71:1842-1849.
15. Stabenow, D., M. Frings, C. Trück, K. Gärtner, I. Förster, C. Kurts, T. Tüting, M. Odenthal, H. P. Dienes, K. Cederbrant, et al. 2010. Bioluminescence imaging allows measuring CD8 T cell function in the liver. Hepatology 51:1430-1437.
16. Semmling, V., V. Lukacs-Kornek, C. A. Thaiss, T. Quast, K. Hochheiser, U. Panzer, J. Rossjohn, P. Perlmutter, J. Cao, D. I. Godfrey, et al. 2010. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat. Immunol. 11:313-320.
17. Talmadge, J. E., J. Adams, H. Phillips, M. Collins, B. Lenz, M. Schneider, and M. Chirigos. 1985. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose. Cancer Res. 45:1066-1072.
18. + T cell-dendritic cell interaction. Nature 440:890-895.
19. Bogdan, C., J. Mattner, and U. Schleicher. 2004. The role of type I interferons in non-viral infections. Immunol. Rev. 202:33-48.
20. Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. Kalinke, and D. F. Tough. 2006. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176:2074-2078.
21. Diamond, M. S., M. Kinder, H. Matsushita, M. Mashayekhi, G. P. Dunn, J. M. Archambault, H. Lee, C. D. Arthur, J. M. White, U. Kalinke, et al. 2011. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208:1989-2003.
22. + T cell response during cross-priming. J. Immunol. 176:4682-4689.
23. Rock, K. L., and H. Kono. 2008. The inflammatory response to cell death. Annu. Rev. Pathol. 3:99-126.
24. Scheu, S., P. Dresing, and R. M. Locksley. 2008. Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. USA 105:20416-20421.
25. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:1219-1226.
26. Kim, C. C., C. S. Nelson, E. B. Wilson, B. Hou, A. L. De Franco, and J. L. De Risi. 2012. Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control. PLoS One 7:e48126.
27. Datta, S. K., V. Redecke, K. R. Prilliman, K. Takabayashi, M. Corr, T. Tallant, J. Di Donato, R. Dziarski, S. Akira, S. P. Schoenberger, and E. Raz. 2003. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170:4102-4110.